Inside the 2026 Biotech Landscape: Innovation, Investment and Global Momentum

In this episode of Denatured, Jennifer Smith-Parker speaks to Kenneth Galbraith, ⁠CEO of Zymeworks and Josh Smiley, president and COO of Zai Lab, about how renewed confidence is driving biotech entering 2026.

Scroll to Top